Literature DB >> 30732861

The war on antidepressants: What we can, and can't conclude, from the systematic review of antidepressant withdrawal effects by Davies and Read.

Sameer Jauhar1, Joseph Hayes2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30732861      PMCID： PMC7613096          DOI： 10.1016/j.addbeh.2019.01.025

Source DB:  PubMed          Journal:  Addict Behav        ISSN： 0306-4603            Impact factor:   4.591


× No keyword cloud information.
  17 in total

1.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  Ann Intern Med       Date:  2009-07-20       Impact factor: 25.391

2.  A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.

Authors:  Stuart A Montgomery; Rico Nil; Natalie Dürr-Pal; Henrik Loft; Jean-Philippe Boulenger
Journal:  J Clin Psychiatry       Date:  2005-10       Impact factor: 4.384

3.  Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.

Authors:  Aytekin Sir; Russell F D'Souza; Sukru Uguz; Tom George; Simavi Vahip; Malcolm Hopwood; Andrew J Martin; William Lam; Tal Burt
Journal:  J Clin Psychiatry       Date:  2005-10       Impact factor: 4.384

4.  Abrupt and brief discontinuation of antidepressant treatment: effects on cognitive function and psychomotor performance.

Authors:  I Hindmarch; S Kimber; S M Cockle
Journal:  Int Clin Psychopharmacol       Date:  2000-11       Impact factor: 1.659

5.  Safety of abrupt discontinuation of fluoxetine: a randomized, placebo-controlled study.

Authors:  J Zajecka; J Fawcett; J Amsterdam; F Quitkin; F Reimherr; J Rosenbaum; D Michelson; C Beasley
Journal:  J Clin Psychopharmacol       Date:  1998-06       Impact factor: 3.153

6.  Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

Authors:  J F Rosenbaum; M Fava; S L Hoog; R C Ascroft; W B Krebs
Journal:  Biol Psychiatry       Date:  1998-07-15       Impact factor: 13.382

7.  Clinical experience with imipramine (G22355) in the treatment of depression.

Authors:  A M MANN; A S MACPHERSON
Journal:  Can Psychiatr Assoc J       Date:  1959-01

8.  The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study.

Authors:  Aung Tint; Peter M Haddad; Ian M Anderson
Journal:  J Psychopharmacol       Date:  2008-05       Impact factor: 4.153

9.  Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.

Authors:  S Oehrberg; P E Christiansen; K Behnke; A L Borup; B Severin; J Soegaard; H Calberg; R Judge; J K Ohrstrom; P M Manniche
Journal:  Br J Psychiatry       Date:  1995-09       Impact factor: 9.319

10.  Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.

Authors:  S A Montgomery; S H Kennedy; G D Burrows; M Lejoyeux; I Hindmarch
Journal:  Int Clin Psychopharmacol       Date:  2004-09       Impact factor: 1.659
View more
  5 in total

1.  Mood matters: a national survey on attitudes to depression.

Authors:  John R Kelly; Mary Cosgrove; Cian Judd; Kathy Scott; Aoibheann Mc Loughlin; Veronica O'Keane
Journal:  Ir J Med Sci       Date:  2019-04-02       Impact factor: 1.568

2.  The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.

Authors:  Anne Guy; Marion Brown; Stevie Lewis; Mark Horowitz
Journal:  Ther Adv Psychopharmacol       Date:  2020-11-09

3.  Antidepressants, withdrawal, and addiction; where are we now?

Authors:  Sameer Jauhar; Joseph Hayes; Guy M Goodwin; David S Baldwin; Philip J Cowen; David J Nutt
Journal:  J Psychopharmacol       Date:  2019-05-21       Impact factor: 4.562

Review 4.  Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.

Authors:  Willemijn Scholten; Neeltje Batelaan; Anton Van Balkom
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-10

5.  Antidepressant withdrawal - the tide is finally turning.

Authors:  Michael P Hengartner; James Davies; John Read
Journal:  Epidemiol Psychiatr Sci       Date:  2019-08-22       Impact factor: 6.892
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.